Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Development
August 28, 2018 10:10 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on...